ArticleHealth science reports2024
Dabrafenib plus Trametinib: A breakthrough in pediatric low-grade glioma therapy.
Marrium Sultan Dar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it